New MA chairman starts
November 5, 2013
Martin Cross has taken up his
new role as chairman of Medicines
Australia (PD 25 Jun), saying
he’s “delighted to be taking up
this most important position for
the medicines industry and the
Australian community.”
“This is a critical time for the
Australian medicines industry as it
is facing huge challenges while also
offering so much opportunity for
the future,” Cross said.
Cross has had a long
pharmaceutical industry career,
with roles including as md of
Alphapharm, Chair of the Generic
Medicines Industry Association
and Chair of the Pharmaceutical
Industry Council.
He was also formerly md of
Novartis in Australia and a member
of the Medicines Australia Board.
He has also previously worked
over many years for ICI, Zeneca and
AstraZeneca, another Medicines
Australia member company.
He replaces AstraZeneca md
Mark Fladrich, who stepped in
as Chairman and led MA for nine
months through a difficult period
for the industry.
“His leadership has been
important in setting the industry’s
direction for the future,” said the
organisation’s ceo, Brendan Shaw.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Nov 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Nov 13
